A Study to Evaluate the Efficacy and Safety of Fixed-Dose Combination of Pitavastatin/Ezetimib
NCT06314919
·
clinicaltrials.gov ↗
RECRUITING
Status
8606
Enrollment
INDUSTRY
Sponsor class
Conditions
Primary Hypercholesterolemia
Mixed Dyslipidemia
Sponsor
Boryung Pharmaceutical Co., Ltd